Join INFRAFRONTIER-IMPC Satellite Event at ICRI 2022

10. 10. 2022 Information News

Global and European Infrastructures IMPC and INFRAFRONTIER Towards the Deciphering of Gene Functions for Human Health

18 October 2022, 13:00 – 15:00 

Hybrid event (Brno, Czech Republic + Zoom)

European and world-wide research infrastructures such as IMPC and INFRAFRONTIER will provide comprehensive resources to unravel gene function in physiology and disease. These infrastructures are used globally to model human biology and disease, enabling therapeutic discovery and precision medicine. In the satellite event, together with colleagues from the rare diseases and gene therapy fields and from the research infrastructures BBMRI (biobanking resources), EATRIS (translational research) and ECRIN (multinational clinical studies), we will showcase and discuss our contributions and the best way forward to serve the research community.

Registration

On-site attendance is by invitation only. Please register here

For on-line participation please registrer here.

Draft Agenda

PresentationSpeakerAffiliation
Introduction and Setting the SceneAlison AbbottJournalist
European and International Research Infrastructures for Addressing Health-related Societal ChallengesRadislav SedlacekCzech Center for Phenogenomics
EATRIS – Accelerating the development of Advanced Therapy Medicinal Products, a Research Infrastructure PerspectiveDavid MorrowEATRIS ERIC
IMPC  – Worldwide Infrastructure for Transformative Insights into the Genetic Basis of DiseaseYann HeraultPHENOMIN-ICS
BBMRI – Fostering Genomic Medicine from Patients’ Consent via Research to Clinical ApplicationJens HabermannBBMRI ERIC
Rare Diseases TBAGabrielle LemireBroad Institute of MIT and Harvard
ECRIN – Genome, phenome and exposome as the three pillars of personalised medicineJacques DemotesECRIN
Human Gene Function Research in Rare Diseases: the European Joint Programme on Rare Diseases Support, Implementations and ForesightYanis MimouniEJP RD
INFRAFRONTIER – Pan-European Research Infrastructure for Modelling Human DiseasesMartin Hrabe de AngelisINFRAFRONTIER
Panel Discussion moderated by Allison AbbottAll Speakers Various
Closing Remarks Martin Hrabe de Angelis, Radislav Sedlacek and Allison Abbott Various